Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
87.05 SEK | -1.25% | -1.86% | -19.38% |
Jun. 14 | Enveda Therapeutics, Inc. announced that it has received $55 million in funding from a group of investors | CI |
Jun. 05 | Kinnevik AB Approves Extra Distribution | CI |
Sales 2024 * | 695M 66.17M | Sales 2025 * | 1.57B 149M | Capitalization | 24.81B 2.36B |
---|---|---|---|---|---|
Net income 2024 * | 622M 59.22M | Net income 2025 * | 1.47B 140M | EV / Sales 2024 * | 39.6 x |
Net Debt 2024 * | 2.68B 255M | Net Debt 2025 * | 6.03B 574M | EV / Sales 2025 * | 19.7 x |
P/E ratio 2024 * |
39.6
x | P/E ratio 2025 * |
16.7
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.98% |
Latest transcript on Kinnevik AB
1 day | -0.11% | ||
1 week | +1.38% | ||
Current month | +1.38% | ||
1 month | -16.86% | ||
3 months | -27.78% | ||
6 months | -13.37% | ||
Current year | -18.46% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 17-12-31 | |
Samuel Sjöström
DFI | Director of Finance/CFO | 37 | 12-12-31 |
Chief Investment Officer | 53 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Anderson
CHM | Chairman | 65 | 21-04-28 |
Director/Board Member | 65 | 18-04-30 | |
Olof Harald Mix
BRD | Director/Board Member | 64 | 21-04-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.88% | 801 M€ | +10.41% | ||
0.61% | 262 M€ | +6.81% | ||
0.24% | 21 M€ | +10.60% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-07-08 | 86.9 | -1.42% | 267 868 |
24-07-05 | 88.15 | -0.11% | 1,012,156 |
24-07-04 | 88.25 | +0.51% | 808,553 |
24-07-03 | 87.8 | -1.40% | 1,294,525 |
24-07-02 | 89.05 | +0.28% | 939,537 |
Delayed Quote Nasdaq Stockholm, July 05, 2024 at 12:00 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.46% | 2.37B | |
+24.10% | 84.25B | |
+11.67% | 17.86B | |
+61.85% | 17.81B | |
+7.94% | 14.57B | |
+26.45% | 12.85B | |
-2.86% | 12.6B | |
+41.12% | 11.13B | |
-1.05% | 11.01B | |
+98.10% | 10.07B |
- Stock Market
- Equities
- KINV B Stock